Her research integrates methods in pharmacoepidemiology and patient preferences, to develop evidence for populations in whom best practices of care are limited such as women, youth, and minority communities. Overall her goal is to inform and improve clinical and policy decision making by providing evidence of benefits or harm of interventions used in real world settings in these populations. She brings an innovative approach into this work, by integrating the patient perspective into pharmacoepidemiology and health services research. Her research agenda focuses on two main topics: 1) improving methods to assess effectiveness of treatments in the context of multimorbidity, and 2) development and implementation of patient-centered methods to address health disparities in minority communities.
